Cite
HARVARD Citation
Siefker-Radtke, A. et al. (2022). Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study. Lancet oncology. 23 (2), pp. 248-258. [Online].